Tanmay Dichwalkar

Tanmay Dichwalkar started their work experience as a Quality Control Analyst at Flamingo Pharmaceuticals Ltd in December 2011, where they worked until April 2012.

They then joined Infinx Services Pvt Ltd in October 2012 as a Process Associate - Pharmacy Billing, where they reviewed and verified physician's prescriptions and documented patient data until February 2013. They then became a Team Coach - Pharmacy Billing at the same company from March 2013 to July 2013.

In June 2014, Tanmay worked as a Research Volunteer at the Icahn School of Medicine at Mount Sinai for three months.

In September 2014, they became a Graduate Research & Thesis Student at Long Island University, where they studied the effects of novel Omega-3 fatty acid linked Paclitaxel dendrimer nanoparticles on various cancer cell lines.

In August 2016, Tanmay joined Massachusetts Institute of Technology (MIT) as a Research Associate II, where they worked until February 2018.

In 2018, Tanmay joined Dragonfly Therapeutics, Inc. as a Research Associate II, and over the years they progressed to roles such as Research Associate III, Senior Research Associate, and currently, Principal Research Associate.

Tanmay Dichwalkar received a Bachelor of Pharmacy (BPharm) degree in Pharmaceutical Sciences from the University of Mumbai from 2007 to 2011. Later, they pursued a Master's Degree in Pharmacology and Toxicology from Long Island University, attending from 2013 to 2016.